Company intelligence / Profile preview

Resurgo Genetics

Cambridge, England, United Kingdom

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Resurgo Genetics was a UK biotechnology company focused on using artificial intelligence and genomics to model cellular interactions and design precise interventions in living systems. The company positioned its work around a computational understanding of non-coding DNA and transcriptional control, with potential applications across medicine, agriculture, and industrial biotechnology. Publicly available information does not show a conventional clinical-stage therapeutic pipeline, and the business appears to have been primarily platform-oriented rather than product-led. Resurgo Genetics was incorporated in 2017, operated from the Babraham Research Campus in Cambridge, and is now in liquidation/closed.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Resurgo Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resurgo Genetics.

Explore the full profile